Recombinant adenovirus vectors deliver BMP-7 genes to joint cells for sustained protein expression and cartilage repair.
Affibody-conjugated hydrogels control BMP-2 release via affinity interactions, reducing off-target effects and improving bone regeneration outcomes.
Defined cytokine cocktails differentiate primate stem cells into hematopoietic lineages, eliminating animal product contamination risks.
Elevated BMP-4 biomarkers predict coronary artery calcification risk, enabling targeted treatment strategies that reduce contrast-induced nephropathy exposure.
Streamlined purification process minimizes protease exposure time to prevent BMP-2 degradation during multi-step chromatography.
Administering follistatin-GDF11 inhibitors restores youthful GDF11 levels, reversing ventricular stiffening and improving diastolic function in aging hearts.
Antibodies targeting sulfonated Sclerostin epitopes enable precise detection of tyrosine modifications.
A BMP10-type peptide determination method quantifies biomarker levels to detect atrial fibrillation presence and subtypes.
Codon-optimized rhBMP-2 nucleotide sequences enable high-yield prokaryotic production while maintaining osteoinductive activity.
Multivalent dendrons anchor bioactive peptides to titanium oxide surfaces via catechol coordination bonds.